+499.5%
MRNA vs DPZ
-25.6%
+525.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | DPZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.7% | -0.5% | -2.1% |
| 7D | +5.5% | -2.5% | +8.0% | +5.8% |
| 30D | +158.7% | -7.0% | +165.7% | +159.9% |
| 3M | +182.1% | +11.6% | +170.5% | +177.5% |
| 6M | +151.8% | -15.2% | +167.0% | +154.3% |
| YTD | +393.6% | -17.2% | +410.8% | +388.1% |
| 1Y | +499.5% | -24.8% | +524.3% | +501.8% |
| All | +499.5% | -25.6% | +525.0% | +501.8% |
Cumulative growth
Daily Returns
Daily percentage return beside DPZ.
Daily Out/Under-Performance
Portfolio return minus DPZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DPZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded DPZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling